>
Genera Biosystems logo

GBI - Genera Biosystems Share Price

A$0.16 0.0  0.0%

Last Trade - 28/06/18

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £499k
Position in Universe th / 1911
Bullish
Bearish
Unlock GBI Revenue
Momentum
Relative Strength (%)
1m -18.0%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2013 2014 2015 2016 2017 2018 2019E 2020E CAGR / Avg
0.044 0.66 1.34 0.62 0.80 0.89 +82.3%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 30 June 2018, GeneraBiosystems Limited revenues increased 11% to A$889K. Netloss increased 17% to A$4.5M. Revenues reflect an increasein demand for the Company's products and services due tofavorable market conditions. Higher net loss reflectsFinance Costs increase of 22% to A$2.4M (expense), EmployeeBenefits Expenses increase of 13% to A$1.6M (expense),Professional Fees increase from A$158K to A$332K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

GBI Revenue Unlock GBI Revenue

Net Income

GBI Net Income Unlock GBI Revenue

Normalised EPS

GBI Normalised EPS Unlock GBI Revenue

PE Ratio Range

GBI PE Ratio Range Unlock GBI Revenue

Dividend Yield Range

GBI Dividend Yield Range Unlock GBI Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
GBI EPS Forecasts Unlock GBI Revenue
Profile Summary

Genera Biosystems Limited is engaged in the development and commercialization of a portfolio of molecular diagnostic test technologies in Australia. The Company is developing a suite of molecular diagnostic testing products based on its AmpaSand bead-based technology. The Company's AmpaSand beads are utilized in its PapType and RTIplex molecular diagnostic tests. It has approximately three additional AmpaSand bead-based multiplexed tests in its development pipeline. PapType is a molecular diagnostic test for the simultaneous detection and genotyping of approximately 14 high-risk and over two low-risk types of human papillomavirus (HPV), the viruses that cause cervical cancer in women and genital warts. RTIplex is an automated assay for the simultaneous detection of approximately 12 viral and over three bacterial respiratory pathogens. The RTIplex kit is used for the detection and identification of over 15 respiratory analytes from nasopharyngeal swab specimens.

Directors
Last Annual June 30th, 2018
Last Interim June 30th, 2018
Incorporated November 6, 2001
Public Since June 11, 2008
No. of Shareholders: n/a
No. of Employees: 10
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange Australian Stock Exchange - SEATS
Shares in Issue 107,466,239
Free Float (0.0%)
Eligible for
ISAs
SIPPs
GBI Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for GBI
Upcoming Events for GBI
Frequently Asked Questions for Genera Biosystems
What is the Genera Biosystems share price?

As of 28/06/18, shares in Genera Biosystems are trading at A$0.16, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Genera Biosystems share price performed this year?

Shares in Genera Biosystems are currently trading at A$0.16 and the price has moved by 39.13% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Genera Biosystems price has moved by 4.24% over the past year.

What are the analyst and broker recommendations for Genera Biosystems?

There are no analysts currently covering Genera Biosystems.

When will Genera Biosystems next release its financial results?

Genera Biosystems is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2019-06-30
What is the Genera Biosystems dividend yield?

Genera Biosystems does not currently pay a dividend.

Does Genera Biosystems pay a dividend?

Genera Biosystems does not currently pay a dividend.

When does Genera Biosystems next pay dividends?

Genera Biosystems does not currently pay a dividend.

How do I buy Genera Biosystems shares?

To buy shares in Genera Biosystems you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Genera Biosystems?

Shares in Genera Biosystems are currently trading at A$0.16, giving the company a market capitalisation of £n/a.

Where are Genera Biosystems shares listed? Where are Genera Biosystems shares listed?

Here are the trading details for Genera Biosystems:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: GBI
What kind of share is Genera Biosystems?

We were not able to load our ranking data for Genera Biosystems

Is there a Genera Biosystems share price forecast 2021?

We were not able to load any forecast data for Genera Biosystems.

How can I tell whether the Genera Biosystems share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Genera Biosystems. Over the past six months, the relative strength of its shares against the market has been -28.29%. At the current price of A$0.16, shares in Genera Biosystems are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Genera Biosystems PE Ratio?

We were not able to find PE ratio data for Genera Biosystems.

Who are the key directors of Genera Biosystems?

We were unable to find the directors for Genera Biosystems.

Who are the major shareholders of Genera Biosystems?

Here are the top five shareholders of Genera Biosystems based on the size of their shareholding:

Similar to GBI
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.